Venous Thromboembolism
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
<i>Objectives.</i> Evidence from case-control studies as well as meta-analyses of these study designs suggest elevated lipoprotein(a) [Lp(a)] to be associated with an increased risk of venous thromboembolism (VTE).
|
31032650 |
2019 |
Venous Thromboembolism
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Before starting TT, we suggest screening for FVL, lipoprotein(a), and the lupus anticoagulant to identify patients at increased VTE risk, with an adverse risk-to-benefit ratio for TT.
|
30577621 |
2018 |
Venous Thromboembolism
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
So we assume a role of lipoprotein(a) as predictor of venous thromboembolism in neoplastic patients.
|
27822883 |
2017 |
Venous Thromboembolism
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature.
|
28346964 |
2017 |
Venous Thromboembolism
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Aim of the study was to investigate the role of LPA gene KIV-2 size polymorphism and single nucleotide polymorphisms (SNPs) (rs1853021, rs1800769, rs3798220, rs10455872) in modulating VTE susceptibility.
|
26900838 |
2016 |
Venous Thromboembolism
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The 2 LPA variants were combined and examined as LPA scores for the association with ischemic stroke (and TOAST [Trial of Org 10172 in Acute Stroke Treatment] subtypes) (effective sample size [n(e)] = 9,396); peripheral arterial disease (n(e) = 5,215); abdominal aortic aneurysm (n(e) = 4,572); venous thromboembolism (n(e) = 4,607); intracranial aneurysm (n(e) = 1,328); CAD (n(e) = 12,716), carotid intima-media thickness (n = 3,714), and angiographic CAD severity (n = 5,588).
|
22898070 |
2012 |
Venous Thromboembolism
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Furthermore, a significant association with recurrent VTE was found for all IT traits except the factor V variant and elevated lipoprotein(a).
|
18779442 |
2008 |
Venous Thromboembolism
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy.
|
12638077 |
2003 |
Venous Thromboembolism
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism.
|
14656611 |
2003 |
Venous Thromboembolism
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Our aim was to assess the contributions of high levels of factor VIII:C, factor XI:C, thrombin activatable fibrinolysis inhibitor (TAFI) and lipoprotein (a) (Lp(a)) to the risk of venous thromboembolism in factor V Leiden carriers.
|
12368162 |
2002 |
Venous Thromboembolism
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.
|
11071628 |
2000 |
Venous Thromboembolism
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.
|
10449697 |
1999 |